---
title: '2026-08-30 DNlite Monitor Audit Report'
description: ''
pubDate: 2026-08-30
category: 'invest'
topic: 'research'
tags: ['研究筆記']
draft: false
source: 'knowledge/DNlite_Reports/2026-08-30_DNlite_Monitor_Audit_Report.md'
nda_cleared: true
nda_notes: '來源為個人 wiki 投資筆記；已通過 NDA 內容檢查（無公司機密、無暫存器設定、無基金持倉）'
---
# 2026-08-30_DNlite_Monitor_Audit_Report

#### 1. Agent Overview
- **Agent Name:** DNlite Regulatory & Clinical Progress Monitor
- **Role:** Daily monitoring of DNlite's regulatory and clinical progress, reporting status changes and updates.
- **Last Audit Date:** N/A (First formal audit)

#### 2. Audit Scope
- **Period:** Weekly: 2026-08-14 to 2026-08-30
- **Areas Reviewed:** Daily monitoring logs in `log.md`, data retrieval methods, and reporting accuracy.

#### 3. Findings
- **Status:** Minor Issues
- **Key Observations:** The agent consistently executes its daily monitoring tasks and successfully retrieves data from various sources, including using `terminal curl` as a robust fallback for ClinicalTrials.gov when direct browser navigation or API calls fail. However, a significant concern is the prolonged stagnation of clinical trial status updates despite general database refreshes.
- **Issues Identified:**
  - **Issue:** Clinical trial statuses for NCT05963126 and NCT06950931 are consistently stale, despite `ClinicalTrials.gov versionHolder` being updated. Primary completion dates for both trials have passed by significant margins (8 and 13 months respectively).
  - **Impact:** Potential for misleading or outdated information regarding the progress of critical clinical trials. This could lead to inaccurate investment decisions if trial progress is assumed without verification.
  - **Evidence:** `log.md` entries for `2026-08-14` (and previous entries indicating similar stagnation).

#### 4. Recommendations
- **Corrective Actions:**
  - Implement a new verification step to actively seek updates for stalled clinical trials through alternative sources (e.g., company press releases, news aggregators, direct stakeholder communication channels if accessible).
  - Develop an alert mechanism that triggers when a clinical trial's estimated primary completion date passes without a status update, prompting further investigation.
- **Preventative Measures:**
  - Enhance the data parsing logic for ClinicalTrials.gov to specifically identify updates to individual trial records, rather than relying solely on the overall `versionHolder` timestamp.
  - Prioritize the use of diverse data sources and cross-verification for critical information, especially when primary sources show prolonged data stagnation.
- **Improvement Areas:** Explore the feasibility of integrating sentiment analysis or news trend monitoring around DNlite and its trials to identify soft signals of progress or issues that may not be captured by structured data sources.

#### 5. Next Steps
- **Follow-up Date:** 2026-09-06 (Next weekly audit)

#### 6. Audit Performed By
- **Auditor:** Chief Auditor
- **Date:** 2026-08-30
